<DOC>
	<DOCNO>NCT02873325</DOCNO>
	<brief_summary>DESIGN : Disease registry - non-interventional . INDICATION : Patients fail first subsequent line treatment adenovirus / cytomegalovirus reactivation post allogeneic hematopoietic stem cell transplantation .</brief_summary>
	<brief_title>Registry Salvage Antiviral Treatment Patients Experiencing ADV / CMV Reactivation Post Allogeneic HSCT</brief_title>
	<detailed_description>In disease registry , data approximately 120 allo HSCT patient receive salvage treatment ( second later line ) antiviral therapy ADV / CMV post allogeneic HSCT document ; 120 , least 40 patient treat Cell Medica 's immune reconstitution ACT salvage therapy . The patient consent prospectively retrospectively collection data . Data collect baseline , 6 month 1 year commencement salvage treatment . Retrospective data collection ( patient underwent HSCT 2010 later ) permit .</detailed_description>
	<mesh_term>Antiviral Agents</mesh_term>
	<criteria>1 . Written inform consent 2 . Physician request salvage ( defined refractory first , requirement second line great ) treatment ADV / CMV reactivation post allogeneic HSCT .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>ADV</keyword>
	<keyword>CMV</keyword>
	<keyword>HSCT</keyword>
</DOC>